Amphivena

Amphivena Therapeutics is a clinical-stage oncology company focused on developing immunotherapies to restore anti-cancer immunity

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

Amphivena Therapeutics is a clinical-stage oncology company focused on developing immunotherapies to restore anti-cancer immunity. Its proprietary Amphivena ReSTORE platform targets immune suppression and T-cell activation.

02Similar Companies

PB

PDS Biotechnology

Biotech & Life Sciences

→

CT

Clasp Therapeutics

Biotech & Life Sciences

→

Is this your company? Claim your profile

M

Micromet

Biotech & Life Sciences

→

NT

Nextpoint Therapeutics

Biotech & Life Sciences

→

AT

Accession Therapeutics

Biotech & Life Sciences

→

03Startup DNA

8

signals

Sectors
Business Model
Technology